TABLE 1.

Demographics and Characteristics of Study Cohort (n = 221)

CharacteristicDataCharacteristicData
Age (y)71 (41–92)Vasodilator
Age, binary Dipyridamole93 (42.1%)
 <65 y73 (33.0%) Regadenoson128 (57.9%)
 ≥65 y148 (67.0%)Heart rate (rest)70.05 ± 13.15
SexHeart rate (stress)87.44 ± 16.56 (2*)
 Female97 (43.9%)Rest systolic blood pressure140.60 ± 20.55
 Male124 (56.1%)Stress systolic blood pressure131.53 ± 22.53 (3*)
Height (cm)168 (132–193)Transient ischemic dilatation ratio1.06 ± 0.15 (1*)
Weight (kg)79 (36–161)Stress MBF (mg/mL/min)1.93 ± 0.74
Body mass index27.82 (16.00–68.78)Rest MBF (mg/mL/min)1.01 ± 0.42
Body mass index, binaryAdjusted rest MBF (mg/mL/min)0.88 ± 0.32
 <30136 (61.5%)MFR2.04 ± 0.74
 ≥3085 (38.5%)Adjusted MFR2.31 ± 0.85
Stress LVEF (%)71 (18–90) (1*)Morise risk assessment
Stress LVEF (%), binary1* Low (0–8)8 (3.6%)
 ≥50198 (90.0%) Intermediate (9–15)93 (42.1%)
 <5022 (10.0%) High (>15)120 (54.3%)
Rest LVEF (%)66 (21–90) (1*)SSS
Rest LVEF (%), binary1* Normal (0–3)169 (76.5%)
 ≥50194 (88.2%) Mild (4–7)26 (11.8%)
 <5026 (11.8%) Moderate (8–11)8 (3.6%)
LVEF reserve5 (-22–21) (1*) Severe (≥12)18 (8.1%)
Abnormal LVEF reserve1*Ischemia (SDS ≥ 3)
 Normal196 (89.1%) Abnormal46 (20.8%)
 Abnormal24 (10.9%) Normal175 (79.2%)
Hemoglobin (g/dL)12.40 (7.60–16.70) (4*)Coronary calcium (Agatston score)5*
Hemoglobin, binary4* None/minimal (0–10)47 (21.8%)
 ≥10 g/dL189 (87.1%) Mild (11–100)37 (17.1%)
 <10 g/dL28 (12.9%) Moderate (101–400)46 (21.3%)
Diabetes Severe (>400)68 (31.5%)
 No143 (64.7%) Stent9 (4.2%)
 Yes78 (35.3%) Coronary artery bypass graft9 (4.2%)
Dyslipidemia157 (71.0%)eGFR (mL/min/1.73 m2)64 (22–109)
Hypertension172 (77.8%)eGFR, binary
Smoker/former smoker159 (71.9%) ≤6096 (43.4%)
History of CAD82 (37.1%) >60125 (56.6%)
  • * Unknown.

  • LVEF = left ventricular ejection fraction; MBF = myocardial blood flow; eGFR = estimated glomerular filtration rate.

  • Qualitative data are number and percentage; continuous data are median and range or mean ± SD.